US Stock MarketDetailed Quotes
RDY Dr. Reddy's Laboratories
- 14.140
- +0.060+0.43%
Close Nov 29 13:00 ET
- 14.228
- +0.088+0.62%
Post 16:17 ET
11.78BMarket Cap18.65P/E (TTM)
14.210High14.100Low565.48KVolume14.100Open14.080Pre Close8.00MTurnover0.07%Turnover Ratio17.88P/E (Static)833.05MShares16.89252wk High3.26P/B11.12BFloat Cap12.82552wk Low0.10Dividend TTM786.45MShs Float16.892Historical High0.67%Div YieldTTM0.78%Amplitude0.724Historical Low14.144Avg Price1Lot Size
Dr. Reddy's Laboratories Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 16.51%80.16B | 13.54%279.16B | 12.49%70.83B | 6.57%72.15B | 9.11%68.8B | 29.20%67.38B | 14.69%245.88B | 15.82%62.97B | 27.26%67.7B | 9.41%63.06B |
| Operating revenue | 16.51%80.16B | 13.54%279.16B | 12.49%70.83B | 6.57%72.15B | 9.11%68.8B | 29.20%67.38B | 14.69%245.88B | 15.82%62.97B | 27.26%67.7B | 9.41%63.06B |
| Cost of revenue | 13.92%32.39B | 8.47%115.56B | 8.81%29.35B | 8.47%29.95B | 10.17%28.43B | 6.44%27.83B | 5.95%106.54B | 5.25%26.97B | 12.29%27.61B | -3.86%25.81B |
| Gross profit | 18.33%47.77B | 17.41%163.61B | 15.24%41.48B | 5.26%42.2B | 8.38%40.37B | 52.09%39.55B | 22.40%139.34B | 25.24%36B | 40.13%40.09B | 20.99%37.25B |
| Operating expense | 29.90%29.72B | 22.43%98.3B | 22.96%28.21B | 12.28%25.3B | 8.94%22.88B | 58.57%21.91B | 3.04%80.29B | 16.38%22.94B | 16.40%22.53B | 6.08%21.01B |
| Selling and administrative expenses | 22.41%23.01B | 13.49%77.2B | 13.81%20.48B | 12.50%20.23B | 13.50%18.8B | 14.26%17.7B | 9.58%68.03B | 14.79%17.99B | 16.68%17.98B | 3.82%16.56B |
| Research and development costs | 33.49%7.27B | 18.02%22.87B | 28.16%6.88B | 15.43%5.57B | 11.87%5.45B | 15.24%4.98B | 10.86%19.38B | 24.04%5.37B | 15.92%4.82B | 9.10%4.87B |
| Other operating expenses | 59.23%-554M | 75.06%-1.78B | 302.86%852M | -82.35%-496M | -221.28%-1.36B | 87.01%-780M | -333.50%-7.12B | -44.33%-420M | -26.51%-272M | 30.88%-423M |
| Operating profit | 3.20%18.05B | 10.59%65.31B | 1.68%13.28B | -3.74%16.91B | 7.66%17.49B | 44.75%17.65B | 64.41%59.05B | 44.55%13.06B | 89.73%17.56B | 47.86%16.24B |
| Net non-operating interest income expense | -125.14%-92M | 328.63%567M | -55.00%54M | 230.34%189M | 493.55%366M | 703.08%784M | -3,642.86%-248M | -86.03%120M | -408.51%-145M | -3,200.00%-93M |
| Non-operating interest income | -7.51%665M | 93.05%2.28B | 36.50%647M | 113.55%583M | 232.87%719M | ---- | 22.28%1.18B | --474M | 4.20%273M | -8.86%216M |
| Non-operating interest expense | 114.45%757M | 19.82%1.71B | 67.51%593M | -5.74%394M | 14.24%353M | ---- | 49.06%1.43B | --354M | 94.42%418M | 32.05%309M |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---784M | ---- | ---- | ---- | ---- |
| Other net income (expense) | -5.38%1.21B | 284.05%6B | 3,431.58%2.68B | 208.40%1.16B | 3,567.57%1.28B | -98.77%32M | 143.03%1.56B | 101.03%76M | -364.69%-1.07B | -102.18%-37M |
| Gain on sale of security | 91.73%1.65B | 10.51%3.43B | 42.56%968M | 12,800.00%774M | 1,463.49%859M | ---- | 46.83%3.1B | --679M | -97.52%6M | -119.94%-63M |
| Earnings from equity interest | 45.24%61M | -60.27%147M | -53.95%35M | -55.00%27M | -70.00%42M | -54.26%43M | -47.37%370M | -27.62%76M | -67.57%60M | -43.32%140M |
| Special income (charges) | -229.32%-494M | 226.75%2.42B | 347.57%1.68B | 131.72%361M | 435.09%382M | -152.38%-11M | 70.36%-1.91B | 90.96%-679M | -5,072.73%-1.14B | -110.08%-114M |
| -Less:Impairment of capital assets | 1,580.00%924M | -99.57%3M | -132.04%-173M | -17.91%110M | 120.00%55M | --11M | -90.76%699M | -92.81%540M | 185.11%134M | --25M |
| -Less:Other special charges | ---- | ---1.52B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | -1.60%430M | 174.32%900M | 88.49%-16M | 146.91%471M | 591.01%437M | ---- | -208.22%-1.21B | ---139M | -4,116.00%-1B | -107.87%-89M |
| Income before tax | 0.17%19.17B | 19.06%71.87B | 20.83%16.02B | 11.69%18.26B | 18.76%19.13B | 25.98%18.46B | 86.91%60.37B | 433.83%13.26B | 68.36%16.35B | 27.05%16.11B |
| Income tax | 32.72%5.75B | 5.79%16.19B | -19.57%2.95B | 15.30%4.47B | -13.02%4.33B | 59.70%4.44B | 75.26%15.3B | 127.80%3.66B | 46.56%3.88B | 80.48%4.98B |
| Net income | -9.36%13.42B | 23.56%55.68B | 36.26%13.07B | 10.57%13.79B | 33.00%14.8B | 18.10%14.03B | 91.22%45.07B | 996.23%9.59B | 76.52%12.47B | 12.18%11.13B |
| Net income continuous Operations | -9.36%13.42B | 23.56%55.68B | 36.26%13.07B | 10.57%13.79B | 33.00%14.8B | 18.10%14.03B | 91.22%45.07B | 996.23%9.59B | 76.52%12.47B | 12.18%11.13B |
| Minority interest income | 862M | 0 | ||||||||
| Net income attributable to the parent company | -15.18%12.55B | 23.56%55.68B | 36.26%13.07B | 10.57%13.79B | 33.00%14.8B | 18.10%14.03B | 91.22%45.07B | 996.23%9.59B | 76.52%12.47B | 12.18%11.13B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -15.18%12.55B | 23.56%55.68B | 36.26%13.07B | 10.57%13.79B | 33.00%14.8B | 18.10%14.03B | 91.22%45.07B | 996.23%9.59B | 76.52%12.47B | 12.18%11.13B |
| Basic earnings per share | -15.29%3.014 | 23.29%66.93 | 36.11%15.732 | 10.28%16.562 | -73.61%3.558 | 17.92%16.8762 | 91.04%54.286 | 996.08%11.558 | 76.35%15.018 | 12.71%13.48 |
| Diluted earnings per share | -15.26%3.01 | 23.32%66.804 | 36.15%15.706 | 10.31%16.536 | -73.45%3.552 | 17.96%16.844 | 91.16%54.17 | 996.58%11.536 | 76.44%14.99 | 12.14%13.378 |
| Dividend per share | 7.9746 | 8.0052 | 0 | 0 | 0 | 8.0052 | 0 | 0 | 0 | 0 |
| Currency Unit | INR | INR | INR | INR | INR | INR | INR | INR | INR | INR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
